Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Four compounds in ear canal secretions differ between those with and without Parkinson’s disease, suggesting they may be ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...

The study indicates that pesticides and poorer water quality could be the cause of higher rates of the disease.

A collaborative study led by Professor Vittoria Raffa at the University of Pisa and Assistant Professor Fabian Raudzus ...